Stay updated with breaking news from Precision Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved the therascreen PDGFRA RGQ PCR kit for use as a companion diagnostic, co-developed by Qiagen and Blueprint Medicines, to assist in the identification of patients with gastrointestinal stromal tumors who may be candidates to receive avapritinib.
Operator: Good morning. Welcome to the Lantheus Second Quarter 2020 Financial Results Conference Call. This is your operator for today's call.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2023 Earnings Call Transcript August 3, 2023 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.54, expectations were $1.33. Operator: Good morning. Welcome to the Lantheus Second Quarter 2020 Financial Results Conference Call. This is your operator for today’s call. [Operator Instructions] This call is being recorded for replay […]
Company Continues to Implement Major Change in Strategy Focused on Acquiring and Operating Accretive Revenue Generating Laboratories and Related...
The decreasing cost of DNA sequencing has contributed to an uptick in genomic sequencing for precision diagnostics in rare diseases.